A comparative study of spironolactone and chlorthalidone in treatment of hypertension
Fagerberg, S.E.; Göransson, K.
Lakartidningen 71(3): 175-177
1974
ISSN/ISBN: 0023-7205 PMID: 4837216 Document Number: 80694
Document emailed within 1 workday
Related Documents
Jamil, M.A. 1971: A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension Guy's Hospital Reports 120(3): 207-219Kreeft, J.H.; Larochelle, P.; Ogilvie, R.I. 1983: Comparison of chlorthalidone and spironolactone in low--renin essential hypertension Canadian Medical Association Journal 128(1): 31-34
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Luis, M.L.; García, J.M.; Jiménez, F.; Jiménez, A.I.; Arias, J.J. 1999: Simultaneous determination of chlorthalidone and spironolactone with univariate and multivariate calibration: wavelength range selection Journal - Association of Official Analytical Chemists 82(5): 1054-1063
de Pasquale, C.; Currò, F.; Amadeo, A. 1978: Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone Minerva Medica 69(31): 2115-2123
Koval, P.G.; McDiarmid, T. 2000: How effective is doxazosin compared with chlorthalidone in the treatment of hypertension? Journal of Family Practice 49(7): 597-598
Maxwell, M.H.; Garrett, B.N.; Saunders, E.; Schnaper, H. 1987: Postmarketing survey of the effects of an atenolol/chlorthalidone combination in the treatment of hypertension Clinical Therapeutics 9(4): 380-389
Angelino, P.F.; Alvino-Demartino, A.; Mappa, R.; Donati, C. 1985: Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 501-505
Akbar, F.A.; Boston, P.F.; Chapman, J.; Pearce, M.Y. 1981: Spironolactone and hydroflumethiazide in the treatment of hypertension British Journal of Clinical Practice 35(9): 317-321
Muiesan, G.; Agabiti-Rosei, E.; Buoninconti, R.; Carotti, A.; Fariello, R.; Innocenti, P.; Toso, M.; Valori, C.; Motolese, M. 1981: A fixed combination of oxprenolol slow-release and chlorthalidone once daily in treatment of mild to moderate hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 19(6): 249-255
Orabona, M.L.; Maiorano, G.; Loiacono, N. 1975: Spironolactone in essential hypertension. Controlled study on the dose-response relationship Minerva Cardioangiologica 23(12): 866-870
Mauro, B.; Savagnone, E. 1979: The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(2): 189-196
Rhomberg, F. 1977: Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension Schweizerische Medizinische Wochenschrift 107(35): 1228-1232
Tosti-Croce, C.; Mantellini, R.; Fanti, P.; Sciarra, F. 1983: Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension Minerva Medica 74(14-15): 791-797
Leonetti, G. 1991: Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension Journal of Cardiovascular Pharmacology 17(Suppl 4): S31-S34
Kamili, M.A.; Allaqaband, G.Q.; Ali, G.; Shah, M.Y.; Sheikh, A.S. 1988: Comparative study of oxprenolol and atenolol in the treatment of hypertension Indian Heart Journal 40(6): 471-474
Collignon-Brach, J.; Weekers, R. 1978: Comparative study of atenolol and timolol in the treatment of ocular hypertension Bulletin de la Societe Belge d'Ophtalmologie 180: 21-26
Pessina, A.C. 1995: Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study La Clinica Terapeutica 146(1): 3-12
De Cesaris, R.; Ranieri, G.; Bonfantino, V.; Adriani, A.; Filitti, V.; Ferrieri, A. 1993: Slow-release nicardipine in the treatment of arterial hypertension: comparative study vs. an ACE inhibitor Minerva Cardioangiologica 41(10): 457-463
Metelitsa, V.I.; Filatova, N.P. 1991: The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy Terapevticheskii Arkhiv 63(8): 30-34